Lin Xichen
Insider CIK 1962926 · GPCR CHIEF SCIENTIFIC OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-09-01 | 2026-09-02 | 17,817 | — | $0 | 125,081 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-09-01 | 2026-09-02 | 5,939 | — | $0 | 5,939 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-09-01 | 2026-09-02 | 1,300 | $45.86 | $59.6K | 4,639 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-09-01 | 2026-09-02 | 4,539 | $47.20 | $214.2K | 100 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-09-01 | 2026-09-02 | 100 | $47.83 | $4.8K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-09-01 | 2026-09-02 | 17,817 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-09-01 | 2026-09-02 | 17,817 | $0.34 | $6.1K | 246,777 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-09-01 | 2026-09-02 | 100 | $47.83 | $4.8K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-09-01 | 2026-09-02 | 4,539 | $47.20 | $214.3K | 100 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-09-01 | 2026-09-02 | 1,300 | $45.86 | $59.6K | 4,639 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-09-01 | 2026-09-02 | 5,939 | — | $0 | 5,939 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-09-01 | 2026-09-02 | 17,817 | — | $0 | 125,081 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-09-01 | 2026-09-02 | 17,817 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-09-01 | 2026-09-02 | 17,817 | $0.34 | $6.1K | 246,777 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-18 | 2026-08-19 | 400 | $55.05 | $22.0K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-08-18 | 2026-08-19 | 3,939 | — | $0 | 3,939 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-18 | 2026-08-19 | 3,020 | $53.13 | $160.5K | 919 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-18 | 2026-08-19 | 519 | $54.20 | $28.1K | 400 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-08-18 | 2026-08-19 | 11,817 | — | $0 | 142,898 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-08-18 | 2026-08-19 | 11,817 | $0.34 | $4.0K | 240,777 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-08-18 | 2026-08-19 | 11,817 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-18 | 2026-08-19 | 400 | $55.05 | $22.0K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-18 | 2026-08-19 | 519 | $54.20 | $28.1K | 400 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-18 | 2026-08-19 | 3,020 | $53.13 | $160.5K | 919 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-08-18 | 2026-08-19 | 3,939 | — | $0 | 3,939 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-08-18 | 2026-08-19 | 11,817 | — | $0 | 142,898 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-08-18 | 2026-08-19 | 11,817 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-08-18 | 2026-08-19 | 11,817 | $0.34 | $4.0K | 240,777 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-08-04 | 2026-08-05 | 11,817 | — | $0 | 154,715 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-04 | 2026-08-05 | 839 | $50.03 | $42.0K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-08-04 | 2026-08-05 | 3,939 | — | $0 | 3,939 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-04 | 2026-08-05 | 3,100 | $49.29 | $152.8K | 839 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-08-04 | 2026-08-05 | 11,817 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-08-04 | 2026-08-05 | 11,817 | $0.34 | $4.0K | 240,777 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-04 | 2026-08-05 | 839 | $50.03 | $42.0K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-08-04 | 2026-08-05 | 3,100 | $49.29 | $152.8K | 839 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-08-04 | 2026-08-05 | 3,939 | — | $0 | 3,939 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-08-04 | 2026-08-05 | 11,817 | — | $0 | 154,715 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-08-04 | 2026-08-05 | 11,817 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-08-04 | 2026-08-05 | 11,817 | $0.34 | $4.0K | 240,777 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-07-14 | 2026-07-15 | 23,634 | — | $0 | 166,532 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-07-14 | 2026-07-15 | 7,878 | — | $0 | 7,878 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-07-14 | 2026-07-15 | 1,600 | $51.71 | $82.7K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-07-14 | 2026-07-15 | 6,278 | $50.80 | $318.9K | 1,600 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-07-14 | 2026-07-15 | 23,634 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-07-14 | 2026-07-15 | 23,634 | $0.34 | $8.0K | 252,594 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2026-06-25 | 2026-06-29 | 23,634 | — | $0 | 190,166 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2026-06-25 | 2026-06-29 | 7,878 | — | $0 | 7,878 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2026-06-25 | 2026-06-29 | 7,878 | $49.08 | $386.7K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2026-06-25 | 2026-06-29 | 23,634 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2026-06-25 | 2026-06-29 | 23,634 | $0.34 | $8.0K | 252,594 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2026-03-19 | 2026-03-23 | 53,703 | — | $0 | 53,703 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award | 2026-03-19 | 2026-03-23 | 43,368 | — | $0 | 228,960 | SEC↗ |
| GPCR Structure Therapeutics Inc | F Tax w/h | 2026-03-03 | 2026-03-05 | 18,735 | $20.99 | $393.2K | 185,592 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award | 2025-07-01 | 2025-07-03 | 57,078 | — | $0 | 217,173 | SEC↗ |
| GPCR Structure Therapeutics Inc | F Tax w/h | 2025-07-01 | 2025-08-20 | 12,846 | $6.84 | $87.9K | 204,327 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2025-03-15 | 2025-03-18 | 196,386 | — | $0 | 196,386 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award | 2025-03-15 | 2025-03-18 | 80,829 | — | $0 | 166,536 | SEC↗ |
| GPCR Structure Therapeutics Inc | F Tax w/h | 2025-03-01 | 2025-07-03 | 6,441 | $7.92 | $51.0K | 160,095 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2024-06-03 | 2024-06-05 | 17,700 | $50.00 | $885.0K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | S Sale deriv | 2024-06-03 | 2024-06-05 | 17,700 | $45.00 | $796.5K | 17,700 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise deriv | 2024-06-03 | 2024-06-05 | 106,200 | — | $0 | 213,800 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion deriv | 2024-06-03 | 2024-06-05 | 35,400 | — | $0 | 35,400 | SEC↗ |
| GPCR Structure Therapeutics Inc | C Conversion | 2024-06-03 | 2024-06-05 | 106,200 | — | $0 | 85,707 | SEC↗ |
| GPCR Structure Therapeutics Inc | M Exercise | 2024-06-03 | 2024-06-05 | 106,200 | $0.34 | $36.1K | 191,907 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2024-03-15 | 2024-03-19 | 213,486 | — | $0 | 213,486 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2024-03-15 | 2024-03-20 | 213,486 | — | $0 | 213,486 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award | 2024-03-15 | 2024-03-19 | 85,707 | — | $0 | 85,707 | SEC↗ |